New
Acorai
The AI engine Fit Assessment
BetaThe company will be attending ViVE 2025 Event
Blurb
Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.
HQ Location
Helsingborg (Sweden)
Founded
2019
Employees
11 - 50
Total funding raised
$15.84M
Last Funding Event
Venture - Series Unknown, $4.41M, December 2, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of a scalable medical device designed for non-invasive intracardiac pressure monitoring to improve heart failure management. The company offers accurate and cost-efficient heart failure care using patented technology that leverages a novel combination of sensor technologies and machine learning to enable non-invasive ICPM, the only proven way to improve outcomes in heart failure patients, enabling healthcare personnel to adjust medication proactively and reduce both heart failure re-hospitalization and mortality rates.